Daily interferon alpha-2B and ribavirin combination therapy for liver transplant patients with chronic hepatitis C infection

Transplant Proc. 2003 Sep;35(6):2080-1. doi: 10.1016/s0041-1345(03)00681-x.

Authors

S Beckebaum¹, V R Cicinnati, M Karliova, O Dirsch, Y Erim, A Frilling, M Malago, C E Broelsch, U Treichel, G Gerken

Affiliation

¹ Department of General Surgery and Transplantation, University Hospital Essen, Essen, Germany. susanne.beckebaum@uni-essen.de

PMID: 14529846
DOI: 10.1016/s0041-1345(03)00681-x

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antiviral Agents / therapeutic use*
Drug Therapy, Combination
Female
Hepatitis C, Chronic / drug therapy*
Hepatitis C, Chronic / surgery*
Humans
Interferon alpha-2
Interferon-alpha / therapeutic use*
Liver Function Tests
Liver Transplantation*
Male
Middle Aged
Polymerase Chain Reaction
Postoperative Complications / drug therapy
Postoperative Complications / virology
RNA, Viral / blood
Recombinant Proteins
Recurrence
Ribavirin / therapeutic use*
Treatment Outcome
Viral Load

Substances

Antiviral Agents
Interferon alpha-2
Interferon-alpha
RNA, Viral
Recombinant Proteins
Ribavirin